Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Coenzyme Q10
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : CoQ10 is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Glaucoma, Open-Angle.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
July 30, 2019
Lead Product(s) : Coenzyme Q10
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Coqun
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability Study of COQUN ORAL FORMULATION
Details : Coqun is a Enzyme drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
January 28, 2019
Lead Product(s) : Coqun
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable